Alcentra Capital (NASDAQ:ABDC) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Thursday.

ABDC has been the topic of a number of other reports. Keefe, Bruyette & Woods set a $7.00 target price on shares of Alcentra Capital and gave the stock a “hold” rating in a report on Thursday, March 15th. UBS raised shares of Alcentra Capital from an “underperform” rating to a “market perform” rating in a report on Thursday, January 11th. Finally, Raymond James Financial raised shares of Alcentra Capital from an “underperform” rating to a “market perform” rating in a report on Thursday, January 11th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the stock. Alcentra Capital has an average rating of “Hold” and a consensus price target of $12.00.

How to Become a New Pot Stock Millionaire

Shares of Alcentra Capital stock opened at $6.74 on Thursday. Alcentra Capital has a 1-year low of $5.93 and a 1-year high of $14.73. The firm has a market cap of $86.94, a P/E ratio of -4.99 and a beta of 0.55.

In other news, insider Branko Krmpotic acquired 10,000 shares of Alcentra Capital stock in a transaction dated Tuesday, March 20th. The shares were bought at an average cost of $6.15 per share, with a total value of $61,500.00. Following the purchase, the insider now owns 14,000 shares in the company, valued at approximately $86,100. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Over the last ninety days, insiders bought 13,750 shares of company stock worth $84,638. Insiders own 4.96% of the company’s stock.

Several large investors have recently bought and sold shares of ABDC. Royal Bank of Canada boosted its stake in shares of Alcentra Capital by 1,948.4% in the 2nd quarter. Royal Bank of Canada now owns 8,808 shares of the asset manager’s stock valued at $120,000 after purchasing an additional 8,378 shares during the last quarter. Commerce Bank bought a new stake in shares of Alcentra Capital in the 3rd quarter valued at $159,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of Alcentra Capital in the 3rd quarter valued at $123,000. Stephens Inc. AR bought a new stake in shares of Alcentra Capital in the 3rd quarter valued at $253,000. Finally, Wasatch Advisors Inc. boosted its stake in shares of Alcentra Capital by 82.9% in the 3rd quarter. Wasatch Advisors Inc. now owns 34,124 shares of the asset manager’s stock valued at $365,000 after purchasing an additional 15,469 shares during the last quarter. 35.01% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://www.watchlistnews.com/alcentra-capital-abdc-upgraded-to-buy-at-valuengine/1954619.html.

Alcentra Capital Company Profile

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.